{
  "id": "Atropine_dosing_cholinesterase_inhibitor_toxicity.v0",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-06-23",
      "name": "Therese Lindberg",
      "organisation": "Cambio CDS",
      "email": "therese.lindberg@cambio.se"
    },
    "lifecycle_state": "Initial",
    "details": {
      "en": {
        "id": "en",
        "purpose": "Doses atropine for cholinesterase inhibitor toxicity (prescribed drugs, nerve gas, insecticides). This dosing guide was created to facilitate early and safe atropinization of the patient exhibiting signs of acute cholinergic toxicity.",
        "keywords": [
          "atropine dosing",
          " cholinesterase inhibitor toxicity",
          "adult",
          "pediatric",
          "severity",
          "dose"
        ],
        "use": "Use in patients with cholinergic toxicity to determine atropine bolus dose and continuous infusion rate.\nThis dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a pharmacist when necessary.\n\nUse for patients with cholinergic toxicity (causative agents are typically organophosphate compounds or carbamate, found in pesticides, or agents used in chemical warfare and terrorist attacks).\nMany symptoms of cholinergic toxicity are recalled with the “SLUDGE and killer B’s” mnemonic:\nSalivation.\nLacrimation.\nUrination.\nDefecation.\nGastric Emesis.\nBradycardia.\n\nAssess for atropinization every 5 minutes:\nClear lung exam on auscultation is the most important factor.\nAdditional factors: heart rate >80, systolic blood pressure >80.\n\nIf atropinization has not been achieved, double previous dose and reassess in another 5 minutes. Repeat doubling every 5 minutes until atropinization achieved. Once atropinization achieved, begin continuous infusion at an hourly rate of 10% of the sum of all doses necessary to achieve initial atropinization.\nTitrate as necessary.",
        "misuse": "Not for use in treating isolated bradycardia.\nNot for use in AtroPen Atropine Auto-Injector dosing.",
        "copyright": "Cambio CDS"
      }
    },
    "other_details": {
      "references": "1. Howland, MA Antidotes in Depth: Atropine. In: Hoffman R, Howland MA, Lewin N et al. Goldfrank's Toxicologic Emergencies, Tenth Edition. McGraw-Hill Education / Medical; 2014."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0003": {
        "id": "gt0003",
        "model_id": "openEHR-EHR-EVALUATION.atropine_dosing_cholinesterase_inhibitor_toxicity.v0",
        "template_id": "openEHR-EHR-EVALUATION.atropine_dosing_cholinesterase_inhibitor_toxicity.v0",
        "type": "INPUT",
        "elements": {
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/items[at0012]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/items[at0005]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/items[at0015]"
          }
        }
      },
      "gt0005": {
        "id": "gt0005",
        "model_id": "openEHR-EHR-EVALUATION.atropine_dosing_cholinesterase_inhibitor_toxicity.v0",
        "template_id": "openEHR-EHR-EVALUATION.atropine_dosing_cholinesterase_inhibitor_toxicity.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/items[at0010]"
          },
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/items[at0011]"
          }
        }
      }
    },
    "rules": {
      "gt0013": {
        "id": "gt0013",
        "priority": 4,
        "when": [
          "$gt0004|Adult / Pediatric|==local::at0014|Pediatric|",
          "$gt0007|Severity|==local::at0017|Severe|",
          "$gt0006|Pediatric Weight|!=null"
        ],
        "then": [
          "$gt0009|Dose|.magnitude=0.02*$gt0006.magnitude",
          "$gt0008|Dose information|='First dose of atropine. Assess for atropinization after 5 mins (clear lung exam, HR >80, sBP >80). If not atropinized, double previous dose and reassess in another 5 mins. Repeat doubling and reassessment every 5 mins until atropinization achieved, then begin continuous infusion at an hourly rate of 10% of the SUM of all doses.'",
          "$gt0009|Dose|.precision=2"
        ]
      },
      "gt0011": {
        "id": "gt0011",
        "priority": 3,
        "when": [
          "$gt0004|Adult / Pediatric|==local::at0013|Adult|",
          "$gt0007|Severity|==local::at0017|Severe|"
        ],
        "then": [
          "$gt0009|Dose|=3,mg",
          "$gt0008|Dose information|='First dose of atropine. Assess for atropinization after 5 mins (clear lung exam, HR >80, sBP >80). If not atropinized, double previous dose and reassess in another 5 mins. Repeat doubling and reassessment every 5 mins until atropinization achieved, then begin continuous infusion at an hourly rate of 10% of the SUM of all doses.'"
        ]
      },
      "gt0012": {
        "id": "gt0012",
        "priority": 2,
        "when": [
          "$gt0004|Adult / Pediatric|==local::at0013|Adult|",
          "$gt0007|Severity|==local::at0016|Mild|"
        ],
        "then": [
          "$gt0009|Dose|=1,mg",
          "$gt0008|Dose information|='First dose of atropine. Assess for atropinization after 5 mins (clear lung exam, HR >80, sBP >80). If not atropinized, double previous dose and reassess in another 5 mins. Repeat doubling and reassessment every 5 mins until atropinization achieved, then begin continuous infusion at an hourly rate of 10% of the SUM of all doses.'"
        ]
      },
      "gt0014": {
        "id": "gt0014",
        "priority": 1,
        "when": [
          "$gt0004|Adult / Pediatric|==local::at0014|Pediatric|",
          "$gt0007|Severity|==local::at0016|Mild|",
          "$gt0006|Pediatric Weight|!=null"
        ],
        "then": [
          "$gt0009|Dose|.magnitude=0.02*$gt0006.magnitude",
          "$gt0008|Dose information|='First dose of atropine. Assess for atropinization after 5 mins (clear lung exam, HR >80, sBP >80). If not atropinized, double previous dose and reassess in another 5 mins. Repeat doubling and reassessment every 5 mins until atropinization achieved, then begin continuous infusion at an hourly rate of 10% of the SUM of all doses.'",
          "$gt0009|Dose|.precision=2"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Atropine dosing cholinesterase inhibitor toxicity",
            "description": "Doses atropine for cholinesterase inhibitor toxicity (prescribed drugs, nerve gas, insecticides)."
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Adult / Pediatric",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "Pediatric Weight",
            "description": "*"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Severity",
            "description": "*"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Dose information",
            "description": "*"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Dose",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Adult Dose - Mild "
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Adult Dose - Severe"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Adult Dose - MIld"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "Pediatric Dose- Severe"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Pediatric Dose - Mild"
          }
        }
      }
    }
  }
}